Core Viewpoint - Tenet Healthcare reported strong Q3 2025 earnings, with adjusted EPS of $3.70, exceeding estimates by 11.1% and showing a year-over-year increase of 26.3% [2][3]. Financial Performance - Net operating revenues for Q3 2025 reached $5.3 billion, a 3.2% increase year over year, surpassing consensus estimates by 1% [2][3]. - Adjusted net income rose to $328 million, reflecting a 16.3% year-over-year growth [4]. - Adjusted EBITDA improved by 12.4% year over year to $1.1 billion, exceeding estimates [4]. - Total operating costs increased by 8.9% year over year to $4.5 billion, primarily due to higher supplies expenses [5]. Segment Performance - **Hospital Operations and Services**: - Net operating revenues were $4 billion, up 0.7% year over year, driven by improved same-hospital admissions and a favorable payer mix [6]. - Adjusted EBITDA for this segment climbed 12.6% year over year to $607 million [7]. - **Ambulatory Care**: - Net operating revenues increased by 11.9% year over year to $1.3 billion, supported by facility buyouts and service line expansions [8]. - Adjusted EBITDA reached $492 million, a 12.1% year-over-year increase [9]. Financial Position - As of September 30, 2025, Tenet had cash and cash equivalents of $3 billion, a decline of 1.5% from the end of 2024 [10]. - Total assets increased to $29.4 billion from $28.9 billion at the end of 2024 [10]. - Long-term debt slightly increased to $13.1 billion, while total shareholders' equity decreased by 3.8% to $4 billion [11]. Share Repurchase and Outlook - In Q3 2025, Tenet repurchased shares worth $93 million, with an authorization of approximately $1.7 billion remaining [12]. - The company raised its 2025 revenue outlook to $21.15-$21.35 billion, indicating a 2.8% growth from 2024 [13]. - Adjusted EBITDA is now expected to be between $4.47 billion and $4.57 billion, reflecting a 13% growth from 2024 [15]. Industry Context - Tenet is part of the Zacks Medical - Hospital industry, where Universal Health Services reported a 13.4% year-over-year revenue increase in its latest quarter [22]. - Universal Health Services has a Zacks Rank 1 (Strong Buy), contrasting with Tenet's Zacks Rank 3 (Hold) [20][23].

Core Conclusion - Far East Horizon Limited, listed on the Hong Kong Stock Exchange in 2011, has evolved into a comprehensive group with financial services as its "shield" and industrial operations as its "spear" [1] - The company's subsidiary, Hongxin Jianda, successfully listed on the Hong Kong Stock Exchange in 2023, becoming China's largest equipment operation service provider [1] - The company is optimistic about its stable leasing investment and decreasing cost of liabilities, as well as the net profit expansion of its industrial operations under its overseas strategy, initiating coverage with a "Buy" rating [1] Business Segments - Far East Horizon's main business encompasses two segments: financial services and industrial operations, with financial services centered on leasing and diversified innovative financial services [1] - The industrial operations segment includes equipment operations led by Hongxin Jianda and hospital operations led by Hongxin Health [1] - The revenue structure shows a rapid increase in the share of industrial operations, projected to account for 42.71% of total revenue in 2024, up 4.03 percentage points year-on-year, reflecting the effectiveness of the "finance + industry" dual-driven development strategy [1] Financial Services - The financial services segment has maintained stable growth in interest-earning assets while enhancing compliance and risk control measures [1] - The expansion of inclusive finance and the decline in cost of liabilities are expected to further widen the interest margin [1] Industrial Operations - The industrial operations segment integrates industry and finance, leveraging resource and business synergies [1] - Hongxin Jianda is actively pursuing overseas business expansion, achieving steady revenue growth, while Hongxin Health has established 26 private hospitals focusing on under-resourced third and fourth-tier cities, creating a unique hospital network [1] Asset Quality and Risk Management - The company has optimized its asset structure, leading to significant improvements in asset quality while maintaining stability [2] - A prudent project investment strategy has been implemented to strictly control the quality of new business and reduce the scale of urban public projects, effectively controlling the generation of non-performing assets [2] - The non-performing asset formation rates for 2023-2025H are projected at 0.50%, 0.43%, and 0.23%, with non-performing asset provision coverage ratios at 240%, 228%, and 227% respectively [2]

Core Insights - Tenet Healthcare reported revenue of $5.27 billion for the quarter ended June 2025, marking a year-over-year increase of 3.3% and exceeding the Zacks Consensus Estimate by 2.43% [1] - The earnings per share (EPS) for the same period was $4.02, a significant increase from $2.31 a year ago, representing a surprise of 41.55% over the consensus estimate of $2.84 [1] Financial Performance Metrics - Adjusted admissions were reported at 211.52 thousand, below the two-analyst average estimate of 223.82 thousand [4] - Net Operating revenues were $5.27 billion, surpassing the average estimate of $5.13 billion based on four analysts, with a year-over-year change of 3.3% [4] - Net Operating revenues from Ambulatory Care reached $1.27 billion, exceeding the estimated $1.23 billion and reflecting an 11.3% increase compared to the previous year [4] - Hospital Operations and Services generated $4 billion in revenue, compared to the average estimate of $3.92 billion, indicating a 1% year-over-year change [4] - Equity in earnings of unconsolidated affiliates was $61 million, slightly above the average estimate of $60.53 million [4] - Adjusted EBITDA for Hospital Operations and Services was reported at $623 million, exceeding the average estimate of $505.06 million [4] - Adjusted EBITDA for Ambulatory Care was $498 million, slightly above the average estimate of $496.33 million [4] Stock Performance - Tenet's shares have returned 3.3% over the past month, compared to a 5.9% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]